- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06149429
Virtual Reality at End-of-life
The Impact of a Novel Virtual Reality Protocol on Presence and Symptom Severity at the End-of-life.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The purpose of this research is to determine the effect that repeated, personalized virtual reality experiences have on symptom severity, comparing self-reported symptom severity both pre and post each session, and overtime across sessions. We will also determine if this intervention results in a high rating of presence in VR, and if presence is related to the magnitude of the change in symptoms.
H1: Symptom severity will decrease from pre-intervention to post-intervention. H2: The change in symptom severity will be greater in session two than it was in session one.
H3: Presence score will be higher in session two than session one. To recruit 30-40 participants, we will have our clinical team working to help the research team identify eligible participants from their caseloads. We will be including all hospice eligible patients, this includes people who are enrolled in hospice care but also a subset of those who are enrolled in palliative care who qualify for hospice but have refused to or haven't yet transitioned to hospice care. The site serves about 670 (as of May 2023) patients a month. Therefore, it is the researcher's intent to recruit about 3 patents per month, or a total of 30-40 patients (about 5% of the monthly population) over the course of one year.
The intervention that participants will be experiencing is personalized virtual reality experiences. The content of this experience will be determined at the initial visit during which the participant will complete a preference questionnaire which identifies the location they want to "go" to. These experiences will be filmed on the insta360 One R camera by the research coordinator. Each experience will be approximately 20 minutes. To view the videos participants will wear the Oculus Quest 2 virtual reality headset.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Catherine M Mann, EdD
- Phone Number: 716-829-6036
- Email: cmmann@buffalo.edu
Study Contact Backup
- Name: Suzanne S Sullivan, PhD
- Phone Number: 716-829-6036
- Email: sullivsu@upstate.edu
Study Locations
-
-
New York
-
Cheektowaga, New York, United States, 14225
- Recruiting
- Hospice and Palliative Care Buffalo
-
Contact:
- Hannah Maciejewski, MS
- Phone Number: 716-473-8072
- Email: hmaciejewski@palliativecare.org
-
Contact:
- Roseann McNaulty, MSA
- Phone Number: 716-335-4692
- Email: rmcanulty@Palliativecare.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Healthy volunteers are not applicable to this study as they study focuses on pain and symptom management at end-of-life through the virtual reality experience.
Inclusion Criteria:
- Patients who are hospice care eligible as defined by the Medicare Hospice benefit and receive hospice or palliative care from Hospice and Palliative Care Buffalo.
Exclusion Criteria:
- Their Palliative Performance Score (PPS) is below 30.
- They are not cognitively intact (display symptoms of delirium or senility, or have a cognitive diagnosis such as Alzheimer's or Dementia) as measured by the Confusion Assessment Method (CAM) (Inouye et al., 1990)
- They have hearing, vision, or speech impairments that are uncorrected.
- They have current symptoms of or a history of dizziness, nausea, headaches, migraines, seizures, or motion sickness.
- They do not speak English.
- They are not 18 years old.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Single-Arm Open Pilot
Pre- Post-intervention design.
The intervention that participants will be experiencing is personalized virtual reality experiences.
The content of this experience will be determined at the initial visit during which the participant will complete a preference questionnaire which identifies the location they want to "go" to.
These experiences will be filmed on the insta360 One R camera by the research coordinator.
Each experience will be approximately 20 minutes.
To view the videos participants will wear the Oculus Quest 2 virtual reality headset.
|
The intervention that participants will be experiencing is personalized virtual reality experiences.
The content of this experience will be determined at the initial visit during which the participant will complete a preference questionnaire which identifies the location they want to "go" to.
These experiences will be filmed on the insta360 One R camera by the research coordinator.
Each experience will be approximately 20 minutes.
To view the videos participants will wear the Oculus Quest 2 virtual reality headset.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Edmonton Symptom Assessment System - Revised (ESAS)
Time Frame: Two weeks
|
End-of-life symptom assessment
|
Two weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
igroup presence questionnaire (IPQ)
Time Frame: Two weeks
|
Presence during virtual reality experience
|
Two weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Catherine Mann, EdD, SUNY Buffalo
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00007462
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Lawson Health Research InstituteTerminated
Clinical Trials on Personalized virtual reality experience
-
Columbia UniversityActive, not recruitingAnalgesia Management for External Cephalic VersionUnited States
-
Washington University School of MedicineCompleted
-
Massachusetts General HospitalCompletedHealthy | Body Dysmorphic DisordersUnited States
-
Tung Wah CollegeChinese University of Hong Kong; Pok Oi Hospital; Golden Age FoundationNot yet recruitingMental Health Wellness 1 | Physical Disability
-
Seoul National UniversityRecruitingVirtual RealityKorea, Republic of
-
Spectrum Health HospitalsActive, not recruitingPreprocedure AnxietyUnited States
-
Taipei Medical UniversityCompletedQuality of Life | Aging | HappinessTaiwan
-
Royal Cornwall Hospitals TrustCompletedPalliative Care | Hematologic Malignancy | Oncology | End Stage CancerUnited Kingdom
-
BaycrestRecruitingPsychological Distress | End-of-Life | Physical SufferingCanada
-
University Hospital of WalesCompleted